TETRAULT LYNN A. Insider Trading Activity

Average Profitability
1.25%
Insider Buys Quantity
2
Insider Buys Sum
$210,030.00
Insider Sells Quantity
7
Insider Sells Sum
$2.37M

Insider Activity of TETRAULT LYNN A.

According to the SEC Form 4 filings, TETRAULT LYNN A., being in a position of

  1. director at NeoGenomics, Inc.,
    оver the last 12 months, has bought 7000 shares for $56,974, and sold 0 shares,
    over all time since 2015-12-07, has bought 33000 shares for $267,004, and sold 42112 shares for $675,059.
  2. director at Rhythm Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 35000 shares for $1.69M,
    over all time since 2024-08-12, has bought 0 shares, and sold 35000 shares for $1.69M.

Biography of TETRAULT LYNN A.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$56,974120
Sells
$1,690,482480

Comparison of Insiders on Amount of Buys and Sells

2025-05-09PurchaseNeoGenomics, Inc.
NEO
director
7,000
0.0275%
$8.14$56,974+2.52%
2024-09-10SaleRhythm Pharmaceuticals, Inc.
RYTM
director
17,501
0.029%
$49.65$868,923+14.16%
2024-09-09SaleRhythm Pharmaceuticals, Inc.
RYTM
director
3,199
0.0052%
$50.04$160,068+10.56%
2024-08-26SaleRhythm Pharmaceuticals, Inc.
RYTM
director
4,300
0.007%
$50.01$215,029+11%
2024-08-12SaleRhythm Pharmaceuticals, Inc.
RYTM
director
10,000
0.0165%
$44.65$446,462+23.56%
2024-03-04SaleNeoGenomics, Inc.
NEO
director
6,112
0.0048%
$15.97$97,579-7.78%
2018-11-19SaleNeoGenomics, Inc.
NEO
director
26,000
0.0277%
$16.00$415,880+29.7%
2018-11-14SaleNeoGenomics, Inc.
NEO
director
10,000
0.0108%
$16.16$161,600+29.53%
2015-12-21PurchaseNeoGenomics, Inc.
NEO
director
19,000
0.0313%
$8.21$155,990-2.08%
2015-12-07PurchaseNeoGenomics, Inc.
NEO
director
7,000
0.0116%
$7.72$54,040+4.59%
Total: 10
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.